• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Cardiology

CPAP may not decrease cardiovascular events in sleep apnea

byShayna BejaimalandShaidah Deghan, MSc. MD
September 8, 2016
in Cardiology, Chronic Disease, Pulmonology
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. Continuous positive airway pressure (CPAP) use did not decrease the incidence of the primary composite cardiovascular event end point.

2. CPAP did reduce snoring and daytime sleepiness and also improved health-related quality of life and mood.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Obstructive sleep apnea (OSA) is known to be associated with increased risk of cardiovascular events, particularly stroke. CPAP is used as treatment for OSA but its unclear if its use is associated with decreased cardiovascular events. This randomized controlled trial was designed to evaluate the effectiveness of CPAP in reducing the rate of cardiovascular events among patients with OSA.

There was no significant difference in the primary composite outcome of death from cardiovascular causes, myocardial infarction, stroke or hospitalization for unstable angina, heart failure, or transient ischemic attack between the CPAP and sham CPAP groups. These results remained robust through individual analysis as well. However, CPAP did significantly reduce snoring and daytime sleepiness. Improvement in health-related quality of life and mood was also observed.

Click to read the study, published today in NEJM

RELATED REPORTS

Higher sleep apnea-specific hypoxic burden may predict postoperative cardiovascular complications and mortality in obstructive sleep apnea

2 Minute Medicine Rewind March 2, 2026

Relevant Reading: Severity of OSA Is an Independent Predictor of Incident Atrial Fibrillation Hospitalization in a Large Sleep-Clinic Cohort

In-Depth [randomized controlled trial]: This international, multi-center, randomized, parallel-group, open—label trial with blind end-point assessment was conducted in 7 countries from 2008 to 2013. Patients between the ages of 45 and 75 with diagnoses of coronary artery disease or cerebrovascular disease and a diagnosis of moderate-to-severe OSA were included. Patients were excluded if they reported excessive daytime sleepiness, had very severe hypoxemia or had Cheyne-Stokes respirations. Patients were required to have a minimal level of CPAP adherence of 3 hours nightly. Patients were randomly assigned to CPAP therapy with usual care or usual care alone. The primary composite end point was death from cardiovascular events, myocardial infarction, stroke or hospitalization for unstable angina, heart failure, and transient ischemic attack. Secondary end points included other cardiovascular outcomes, health-related quality of life, snoring symptoms, daytime sleepiness and mood.

Of the 2717 eligible participants, 1359 were randomized to CPAP and 1358 randomized to usual care. The mean adherence to CPAP therapy was 3.3 hours per night and the mean apnea-hypopnea index decreased from 29.0 events per hour to 3.7 per hour during follow-up. Patients were followed for a mean of 3.7 years. In the CPAP group, 229 patients (17.0%) incurred the primary end point event; in the usual care group 207 participants (15.4%) incurred the primary end point event (HR with CPAP 1.10; 95%CI 0.91-1.32; p = 0.34). However, the study states that CPAP significantly reduced snoring and daytime sleepiness that was reported by the patient. Lastly, it improved health-related quality of life and mood.

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cpapObstructive Sleep Apnea
Previous Post

Cord blood transplant linked to improved survival and lower relapse rate

Next Post

Current therapies ineffective at reducing epistaxis in hereditary hemorrhagic telangiectasia

RelatedReports

Admission may not be needed following sleep apnea surgery
Cardiology

Higher sleep apnea-specific hypoxic burden may predict postoperative cardiovascular complications and mortality in obstructive sleep apnea

March 4, 2026
Physical fitness collage: a smiling woman in a swim cap with goggles pushed up, in front of a pool lane rope and water
Weekly Rewinds

2 Minute Medicine Rewind March 2, 2026

March 2, 2026
Admission may not be needed following sleep apnea surgery
Chronic Disease

Middle-aged and older Canadians at high risk of obstructive sleep apnea may have worse mental health outcomes

January 12, 2026
Admission may not be needed following sleep apnea surgery
Chronic Disease

Tirzepatide reduces obstructive sleep apnea symptoms and associated risks

October 10, 2024
Next Post

Current therapies ineffective at reducing epistaxis in hereditary hemorrhagic telangiectasia

Adalimumab aids in control of noninfectious uveitis

Adverse pregnancy outcomes associated with thrombophilias [Classics Series]

The SCD-HeFT: ICD vs. amiodarone for congestive heart failure [Classics Series]

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Bariatric surgery associated with lower obesity-related cancer incidence in Nordic cohort
  • Cretostimogene reduced recurrence risk in intermediate-risk and high-grade Ta non-muscle invasive bladder cancer in topline phase 3 results
  • Removing Race and Ethnicity From Dialysis Mortality Risk Adjustment Changes Facility Performance Rankings
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.